Bayer: sales and EBIT at record levels Information about the Cover Picture
Bayer: sales and EBIT at record levels
Chairman’s Letter

Chairman’s Letter

2011: Bayer achieves financial and innovation targets
“Dear Stockholders: It is a great pleasure to present to you Bayer’s Annual Report for 2011,
a very successful year for our company.”
» more


Building on our strengths
How can we improve people’s quality of life? Read what our three subgroups are doing to drive innovation, strengthen marketing and expand our market presence in our multimedia magazine.
» more

Bayer Group

About Bayer Group

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
» more

Key Data

Bayer: sales and EBIT at record levels
On a currency- and portfolio-adjusted (Fx & portfolio adj.) basis, we raised Group sales by 5.5% (reported: +4.1%) to €36.5 billion.
» more

Management Report

Overview of Sales, Earnings and Financial Position
Bayer had a very successful year in 2011, both strategically and operationally. Read more about the overview of Sales, Earnings and Financial Position.
» more

Bayer Stock

Bayer Stock performance above market but below Healthcare Index

The performance of Bayer stock – including the dividend of €1.50 per share paid in May 2011 – came to minus 8 percent for the year.
» more

Copyright © Bayer AG

Special Interest

Print page


Download Center



Full Year 2011 Results


Last updated: February 28, 2012